These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24831337)

  • 21. Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement.
    Hanjani NM; Nousari CH
    Arch Dermatol; 2002 Dec; 138(12):1616-8. PubMed ID: 12472362
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of mycophenolate mofetil with ciclosporine for the treatment of chronic plaque-type psoriasis.
    Beissert S; Pauser S; Sticherling M; Frieling U; Loske KD; Frosch PJ; Haase I; Luger TA
    Dermatology; 2009; 219(2):126-32. PubMed ID: 19546522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thalidomide in the treatment of refractory orofacial granulomatosis.
    Eustace K; Clowry J; Kirby B; Lally A
    Br J Dermatol; 2014 Aug; 171(2):423-5. PubMed ID: 24601875
    [No Abstract]   [Full Text] [Related]  

  • 25. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil.
    Hantash B; Fiorentino D
    Arch Dermatol; 2006 Jan; 142(1):109-10. PubMed ID: 16415398
    [No Abstract]   [Full Text] [Related]  

  • 26. Lichen planus in association with adult-onset still's disease successfully treated with mycophenolate mofetil.
    Emad Y; Ragab Y; El-Shaarawy N
    J Rheumatol; 2012 Jun; 39(6):1305-6. PubMed ID: 22661425
    [No Abstract]   [Full Text] [Related]  

  • 27. Delayed neutrophil engraftment in cord blood transplantation with intensive administration of mycophenolate mofetil for GVHD prophylaxis.
    Okamura A; Shimoyama M; Ishii S; Wakahashi K; Asada N; Kawano H; Kawamori Y; Nishikawa S; Minagawa K; Katayama Y; Matsui T
    Bone Marrow Transplant; 2011 Jan; 46(1):148-9. PubMed ID: 20228852
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral Crohn's disease: is it a separable disease from orofacial granulomatosis? A review.
    Zbar AP; Ben-Horin S; Beer-Gabel M; Eliakim R
    J Crohns Colitis; 2012 Mar; 6(2):135-42. PubMed ID: 22325167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions.
    Dede F; Onec B; Ayli D; Gonul II; Onec K
    Scand J Urol Nephrol; 2008; 42(2):178-80. PubMed ID: 17853044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orofacial granulomatosis of the lip: a report of 2 cases with histological and immunohistochemical analyses and intralesional corticotherapy.
    Martini MZ; Galletta VC; Pereira EM; De Sousa SC; Lemos CA; Migliari DA
    Minerva Stomatol; 2010 Oct; 59(10):579-81. PubMed ID: 21048550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
    Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
    Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation.
    Deierhoi MH; Sollinger HW; Diethelm AG; Belzer FO; Kauffman RS
    Transplant Proc; 1993 Feb; 25(1 Pt 1):693-4. PubMed ID: 8438440
    [No Abstract]   [Full Text] [Related]  

  • 35. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC; Hogan AC; Dick AD; Lee RW
    Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil for Crohn's disease?
    Lowry PW; Sandborn WJ; Lipsky JJ
    Lancet; 1999 Jul; 354(9172):3-4. PubMed ID: 10406354
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.
    Talhari C; Mahnke N; Ruzicka T; Megahed M
    Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction therapy for pediatric focal proliferative lupus nephritis: cyclophosphamide versus mycophenolate mofetil.
    Lau KK; Ault BH; Jones DP; Butani L
    J Pediatr Health Care; 2008; 22(5):282-8. PubMed ID: 18761229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.
    Burchardi C; Schlöndorff D
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):314-5. PubMed ID: 16932452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.